International Patent: RECOMBINANT FST POLYPEPTIDE, FUSION PROTEIN COMPRISING SAME, PHARMACEUTICAL COMPOSITION, AND USE OF FUSION PROTEIN AND PHARMACEUTICAL COMPOSITION

GENEVA, Oct. 5 -- JIANGSU KANION PHARMACEUTICAL CO., LTD. filed a patent application (CN2026/086466) for “RECOMBINANT FST POLYPEPTIDE, FUSION PROTEIN COMPRISING SAME, PHARMACEUTICAL COMPOSITION, AND USE OF FUSION PROTEIN AND PHARMACEUTICAL COMPOSITION”. With publication no. WO/2026/201114, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/47

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....